Fluconazole Resistance in C. Tropicalis by Broth Microdilution Method and to compare the relative gene expression of erg11 gene in both Fluconazole Resistant and Sensitive C Tropiocalis
Explore this paper's citation graph
Summary
C. tropicalis was found to be resistant to fluconazole, and on molecular testing by relative gene expression of ERG11 gene it was noticed that these resistant isolates have 2.0 fold increased mRNA expression levels of this gene as compared to sensitive strains.
- Type
- article
- Published
- 2023-05-27
- Cited by
- 0
- References
- 31
- Access
- Open access
- OpenAlex
- https://openalex.org/W4379015504
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:259031672
Keywords
Candida tropicalis, Fluconazole, Broth microdilution, Microbiology, Biology
References
- Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.
- Antimicrobial Susceptibility Testing Protocols
- Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei
- Antifungal agents: mechanisms of action.
- Invasive candidiasis in the intensive care unit
- Candida tropicalis in human disease
- Vulvovaginal candidiasis: species distribution, fluconazole resistance and drug efflux pump gene overexpression
- Advances in experimental medicine and biology
- Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
- Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.
- Resistance Mechanisms in Clinical Isolates of Candida albicans
- Abc1p Is a Multidrug Efflux Transporter That Tips the Balance in Favor of Innate Azole Resistance in Candida krusei
- Structural basis for heterogeneous phenotype of ERG11 dependent Azole resistance in C.albicans clinical isolates
- Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011
- Reduced Azole Susceptibility in Genotype 3 Candida dubliniensis Isolates Associated with Increased CdCDR1 and CdCDR2 Expression
- Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.
- Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
- Fluconazole resistance in Candida albicans: a review of mechanisms.
- Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance
- Characteristics of biofilm formation by Candida tropicalis and antifungal resistance.
Cited by
No citing papers recorded for this paper.
Related papers
- Sub-inhibitory Concentrations of Antifungals Suppress Hemolysin Activity of Oral Candida albicans and Candida tropicalis Isolates from HIV-Infected Individuals
- The Bovhyaluronidase Azoximer (Longidaza®) Disrupts Candida albicans and Candida albicans-Bacterial Mixed Biofilms and Increases the Efficacy of Antifungals
- In vitro efficacy of liposomal amphotericin B, micafungin and fluconazole against non-albicans Candida species biofilms.
- Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
- CORRELATE BETWEEN BIOFILM FORMATION AND AZOLE ANTIFUNGAL SUSCEPTIBILITY AGAINST PLANKTONIC AND SESSILE CANDIDA ALBICANS CLINICAL ISOLATES
- Arachidonic acid affects biofilm formation and PGE2 level in Candida albicans and non-albicans species in presence of subinhibitory concentration of fluconazole and terbinafine
- Clinical analysis of candidal vaginitis patients and drug resistance.
- Study of Antifungal Susceptibility, Virulence Genes and Biofilm Formation in Candida albicans
- Penetration of Candida Biofilms by Antifungal Agents
- In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi